Evidence map›Paper›PMID 25970810›Full record

ReviewBiochimica et biophysica acta2015

Breaking a pathogen's iron will: Inhibiting siderophore production as an antimicrobial strategy.

Audrey L Lamb

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Bacteria Under Metal Stress-Molecular Mechanisms of Metal Tolerance.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Targeting Siderophore Biosynthesis to Thwart Microbial Growth.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Analysis of the vibrioferrin biosynthetic pathway of Vibrio parahaemolyticus.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
  11. General Overview ofBiology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Structural Studies of Modular Nonribosomal Peptide Synthetases.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  17. Review
  18. Article
  19. Rational inhibitor design for Pseudomonas aeruginosa salicylate adenylation enzyme PchD.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Audrey L LambDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, USA. Electronic address: lamb@ku.edu.

Funding

Structure-function analyses of siderophore biosynthetic enzymesK02AI093675 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI LAMB, AUDREY L · 2011 to 2014
$428k
NIAID NIH HHS K02 AI093675
6 · The paper itself

Abstract

The rise of antibiotic resistance is a growing public health crisis. Novel antimicrobials are sought, preferably developing nontraditional chemical scaffolds that do not inhibit standard targets such as cell wall synthesis or the ribosome. Iron scavenging has been proposed as a viable target, because bacterial and fungal pathogens must overcome the nutritional immunity of the host to be virulent. This review highlights the recent work toward exploiting the biosynthetic enzymes of siderophore production for the design of next generation antimicrobials.

Indexed as

Anti-Infective AgentsBacterial InfectionsMycosesSiderophoresDrug Resistance, BacterialDrug Resistance, FungalIronAnti-Infective AgentsIronSiderophoresNonribosomal peptide synthetaseNRPS-independent synthetasePolyketide synthaseSiderophore

Identifiers

PMID25970810
PMCPMC4457648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.